Veterinary uses of recombinant human granulocyte colony-stimulating factor. Part II. Infectious diseases

Compendium on Continuing Education for the Practicing Veterinarian

Volumn 20, Issue 7, 1998, Pages 823-827

  Rewerts, Jennifer M ^a   Henry, Carolyn J ^b  

^a Veterinary Specialties of Omaha   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; PARVOVIRUS;

EID: 0042742842     PISSN: 01931903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Obradovich JE, Ogilvie GK, Powers BE, et al: Evaluation of recombinant canine granulocyte colony-stimulating factor as an inducer of granulopoiesis. A pilot study. J Vet Intern Med 5:75-79, 1991.
2. Ogilvie GK, Obradovich JE, Cooper MF, et al: Use of recombinant canine granulocyte colony-stimulating factor to decrease myelosuppression associated with the administration of mitoxantrone in the dog. J Vet Intern Med 6:44-47, 1992.
3. Lothrop CDJ, Warren DJ, Souza LM, et al: Correction of canine cyclic hematopoiesis with recombinant human granulocyte colony-stimulating factor. Blood 72:1324-1328, 1988.
4. Kraft W, Kuffer M: Treatment of severe neutropenias in the dog and cat with Filgrastim. Tierarztl Prax 23:609-613, 1995.
5. Tams TR: Management of the canine viral enteritis patient. Proc TNAVC:5-10, 1995.
6. Macartney L, McCandlish IAP, Thompson H, et al: Canine parvovirus enteritis 1: Clinical, haematological and pathological features of experimental infection. Vet Rec 115: 201-210, 1984.
7. Fulton R, Gasper PW, Ogilvie GK, et al: Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats. Exp Hematol 19:759-767, 1991.
8. Obradovich JE, Ogilvie GK, Stadler-Morris S, et al: Effect of recombinant canine granulocyte colony-stimulating factor on peripheral blood neutrophil counts in normal cats. J Vet Intern Med 7:65-67, 1993.
9. Boosinger TR, Rebar AH, DeNicola DB, et al: Bone marrow alterations associated with canine parvoviral enteritis. Vet Pathol 19:558-561, 1982.
10. Brunner CJ, Swango LJ: Canine parvovirus infection: Effects on the immune system and factors that predispose to severe disease. Compend Contin Educ Pract Vet 7(12):979-989, 1985.
11. Maloney MA, Patt HM: Granulocyte transit from bone marrow to blood. Blood 31:195-201, 1968.
12. Weite K, Gabrilove J, Bronchud MH, et al: Filgrastim (r-metHuG-CSF): The first 10 years. Blood 88:1907-1929, 1996.
13. Meunier PC, Cooper BJ, Appel MJG, et al: Pathogenesis of canine parvovirus enteritis: The importance of viremia. Vet Pathol 22:60-7'1, 1985.
14. Cudd T, Koterba AM: The ISVP survey of equine neonatal disease: 1987. Newslett Int Soc Vet Perinatol 1:7-14, 1988.
15. Koterba AM, Brewer BJ, Tarplee F: Clinical and clinicopathologic features of septicaemia in the newborn foal: A review of 38 cases. Equine Vet J 16:312-318, 1984.
16. Eichaker PQ, Waisman Y, Natanson C, et al: Cardiopulmonary effects of granulocyte colony-stimulating factor in a canine model of bacterial sepsis. J Appl Physiol 77:2366-2373, 1995.
17. Zinkl JG, Madigan JE, Fridmann DM, et al: Haematological, bone marrow and clinical chemical changes in neonatal foals given canine recombinant granulocyte-colony stimulating factor. Equine Vet J 26:313-318, 1994.
18. Madigan JE, Zinkl JG, Fridmann DM, et al: Preliminary studies of recombinant bovine granulocyte-colony stimulating factor on haematological values in normal neonatal foals. Equine Vet J 26:159-161, 1994.